Searched for
VP RESEARCH PHARMA
Why did stock market rally today? Sensex jumps 736 points, Nifty closes above 23,850. 5 key factors behind bull runIndian equities surged nearly 1% as bulls charged through Dalal Street, driven by an Iran-US peace framework and sliding oil prices. The Se...- Why market rallied today? Sensex jumps 1,074 points, Nifty closes above 24,000. 5 factors behind surgeIndian stock markets surged on Monday, with Sensex and Nifty rallying over 1% each, driven by rising hopes of a US-Iran peace deal and fall...
- Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defenc...
- D-Street ends week in the green with war and peace on its mindFriday brought a wave of optimism to Indian stock markets, with notable weekly advancements. Nonetheless, investors remained watchful as ta...
- Market wrap: Sensex rises 232 points, Nifty closes above 23,700 as rupee recovers from lifetime lowsIndian markets ended the week higher after recovering intraday volatility, with Sensex and Nifty posting modest gains amid hopes of easing ...
- Selling at higher levels turns 23,800 into key barrier for Nifty: AnalystsBenchmark Nifty closed lower last week. Analysts anticipate continued range-bound trading for Nifty this week. Trading strategies suggest b...
- Sensex surges over 800 points to cross 75,400; Nifty above 23,650 despite weak rupeeIn a recent turn of fortunes, Indian stock markets experienced a notable rise for the second consecutive day. On Thursday, both the Sensex ...
- Why did the stock market fall today? Sensex tumbles 1,300 pts, Nifty below 23,850. 6 key factorsIndian stock markets experienced a significant downturn on Monday. The Sensex and Nifty saw sharp declines as oil prices surged. Fading hop...
- Sensex falls 114 points, Nifty closes below 24,350; broader markets outperformIndian stock markets surged on Thursday, with Sensex and Nifty extending gains for a second day. This rise was fueled by optimism over a po...
- Bulls back on D-St! Sensex rallies over 940 pts, Nifty closes above 24,330. Here's whyIndian stock markets surged over 1% on Wednesday, with the Sensex and Nifty reversing early losses. This rebound was triggered by a report ...
- Sensex falls over 700 points, Nifty below 23,900 as US-Iran launch fresh attacks, rupee tumbles to record lowIndian stock markets tumbled on Tuesday, with Sensex and Nifty falling significantly due to fresh US-Iran war escalations and the rupee hit...
- Why market fell today? Sensex slumps 583 pts, Nifty below 24,000; 7 key triggersIndian stock markets experienced a significant downturn on Thursday, with Sensex and Nifty both falling over 0.7%. This decline was driven ...
- Sensex slips 100 pts, Nifty below 24,100 as fading peace hopes and surging oil prices spook investorsIndian stock markets, Sensex and Nifty, saw a dip on Tuesday. This followed a strong performance the previous day. Investor sentiment was a...
- Sensex jumps 639 pts, Nifty ends above 24,050 to snap 3-day losing run. What drove the rally?Indian markets surged on Monday, ending a losing streak. Investor sentiment improved following reports of Iran sending a peace proposal to ...
- Stock Market Crash Today: D-Street investors lose Rs 5 lakh crore. 7 reasons why Sensex and Nifty fellIndian stock markets experienced sharp losses for the third consecutive session, with Sensex and Nifty falling over 1% each. Escalating Ira...
- Pharma stocks buck market weakness as Dr Reddy's gainsPharma stocks showed strength on Thursday, defying market weakness. Dr Reddy's Laboratories saw significant gains, fueled by anticipation o...
- Why stock market fell today? Sensex plunges 850 pts, Nifty below 24,200. 6 reasons behind selloffIndian equity benchmarks declined for a second straight session, pressured by a spike in crude oil prices, a weakening rupee and rising geo...
- Pharma calls in sick after Trump’s 100% tariff threatPharma stocks fell Thursday after reports of US President Donald Trump mulling 100% tariffs on imported branded and patented medicine maker...
- AstraZeneca rallies over 37% in June on Forxiga launch; more gains likelyAstraZeneca have broken out of the narrow trading range in June, driven by two positive news flows. The stock has rallied 37.41% since June...
- Lupin gains post Q4 results;brokerages raise target priceLupin reported a net profit of Rs 553 cr for the quarter ended March 204, up 35.5%, from Rs 408 cr in the corresponding quarter last fiscal.
Load More
